Showing results (211-220 of 329) with videos related to

Sort By:
Pageof 33
Human Molecular Genetics|February 25, 2016
Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndromeÅsa Johansson, Niclas Eriksson, Daniel Lindholm, et al.
The Journal of Invasive Cardiology|November 5, 2013
Safety of very early sheath removal in patients treated with REG1 for acute coronary syndromes: insights from the RADAR trialJohn P Vavalle, Thomas J Povsic, Laura H Aberle, et al.
Platelets|June 24, 2008
Platelets: developmental biology, physiology, and translatable platforms for preclinical investigation and drug developmentNeal S Kleiman, Jane E Freedman, Paula B Tracy, et al.
The American Journal of Cardiology|October 21, 2009
Six-month follow-up of patients with in-hospital thrombocytopenia during heparin-based anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] registry)Renato D Lopes, E Magnus Ohman, Christopher B Granger, et al.
Plos One|January 4, 2014
A functional polymorphism in the 5HTR2C gene associated with stress responses also predicts incident cardiovascular eventsBeverly H Brummett, Michael A Babyak, Rong Jiang, et al.
Circulation|November 10, 2010
Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysisPhilippe Gabriel Steg, Stefan James, Robert A Harrington, et al.
European Heart Journal|August 30, 2011
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairmentKeith A A Fox, Jonathan P Piccini, Daniel Wojdyla, et al.
European Journal of Preventive Cardiology|January 10, 2017
Mental stress-induced left ventricular dysfunction and adverse outcome in ischemic heart disease patientsJulia L Sun, Stephen H Boyle, Zainab Samad, et al.
Circulation|April 7, 2010
Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) TrialSunil V Rao, Chiara Melloni, Shelley Myles-Dimauro, et al.
Lancet (London, England)|March 17, 2009
Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II studyRichard C Becker, David J Moliterno, Lisa K Jennings, et al.
Pageof 33